# Safety, Tolerability, Efficacy of EA0010 in OTOF Patients With CI

> **NCT07752888** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Shanghai EmayGene Technology Co., Ltd** · enrollment: 1 (actual)

## Conditions studied

- DFNB9
- Cochlear Implantation

## Interventions

- **GENETIC:** EA0010 Injection

## Key facts

- **NCT ID:** NCT07752888
- **Lead sponsor:** Shanghai EmayGene Technology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-05-23
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2026-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07752888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07752888, "Safety, Tolerability, Efficacy of EA0010 in OTOF Patients With CI". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07752888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*